Inclusion of Women in Clinical Trials -- Policies for Population Subgroups
Bennett, J. Claude
New England Journal of Medicine. 1993 Jul 22; 329(4): 288-292.
In summary, neither adherence to quotas in the composition of a study cohort nor the irrational exclusion of a subgroup of people can be supported scientifically. Determining the number of women to be included in a trial should reflect reasonable hypotheses about the relation of treatment efficacy to sex, not global rules about the composition of study cohorts.
Biomedical Research; Cancer; Clinical Trials; Discrimination; Evaluation; Federal Government; Females; Fetuses; Financial Support; Food; Government; Government Regulation; Health; Heart Diseases; Human Experimentation; Males; Pregnant Women; Public Policy; Regulation; Research; Research Design; Research Subjects; Selection of Subjects; Social Discrimination; Women's Health;
Showing items related by title, author, creator and subject.
Bennett, J. Claude (Institute of Medicine (United States) [IOM]. Board on Health Sciences Policy, 1993-07-22)
Inclusion of Women and Minorities in Clinical Trials and the NIH Revitalization Act of 1993 - the Perspective of NIH Clinical Trialists Freedman, Laurence S.; Simon, Richard; Foulkes, Mary A.; Friedman, Lawrence; Geller, Nancy L.; Gordon, David J.; Mowery, Richard (1995-10)
Meinert, Curtis L. (1995-08-11)